Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technology

Optimized formulation for topical application of a fixed combination halobetasol/tazarotene lotion using polymeric emulsion technology

Background Successful clinical data on halobetasol propionate 0.01%/tazarotene 0.045% (HP/TAZ) lotion in moderate-to-severe plaque psoriasis are published. This article charts its formulation development. Methods Dermal deposition, clinical efficacy, and synergistic effect of HP and TAZ delivered by...

Full description

Bibliographic Details
Main Authors: Emil A. Tanghetti, Linda Stein Gold, James Q. Del Rosso, Tina Lin, Arturo Angel, Radhakrishnan Pillai
Format: Article
Language:English
Published: Taylor & Francis Group 2021-05-01
Series:Journal of Dermatological Treatment
Subjects:
psoriasis
halobetasol
tazarotene
lotion
formulation
Online Access:http://dx.doi.org/10.1080/09546634.2019.1668907

Internet

http://dx.doi.org/10.1080/09546634.2019.1668907

Similar Items